CALLE DOCTOR FLEMING, 51 | 28036 MADRID, SPAIN
+34 91 3459395 | +44 (0) 20 3951 8071
info@oxonepi.com

Tag: EVENT

OXON Masterclasses

REGISTER INTEREST FOR OXON’s FREE LIVE ONLINE REAL WORLD MASTERCLASS SERIES 2022-2023

OUR FREE LIVE REAL WORLD MASTERCLASS SERIES WILL BE BACK AFTER THE SUMMER ‘How to ensure success and avoid pitfalls in Real World studies by Understanding Healthcare in Europe and Asia’ Dates: Restarting in September 2023 | Time: 5pm CET | 4pm UK | 11am EST | 8am PST OXON will be resuming the series…
Read more

Global Clinical Trials Connect 2022

OXON’s speaker at the Global Clinical Trials Connect 2022 conference

Nawab Qizilbash will be speaking at the Global Clinical Trial Connect 2022 Virtual Conference and Expo 21 – 22 September 2022 Nawab Qizilbash, Senior Clinical Epidemiologist and Head of OXON will be participating at the Global Clinical Trials Connect 2022 virtual summit on Wednesday 21 September at 13:25h BST | 14:25 CEST. Under the title…
Read more

ICPE2022

OXON AT ICPE Conference – 24-28 August2022

OXON’s real-world studies at the 38th International Conference on PharmacoEpidemiology, ICPE 2022.  Advancing Pharmacoepidemiology and Real-World Evidence for the Global Community August 24-28, 2022 | Bella Center Copenhagen | Copenhagen, Denmark At OXON we are excited to be supporting ICPE 2022 as an exhibitor, presenting our capabilities and research during this in-person event for scientific and…
Read more

OXON Masterclasses

OXON’s FREE LIVE ONLINE REAL WORLD MASTERCLASS SERIES 2022-2023

FREE LIVE REAL WORLD MASTERCLASS SERIES 2022-2023 ‘How to ensure success and avoid pitfalls in Real World studies by Understanding Healthcare in Europe and Asia’ Dates: Monthly starting in February 2022 | Time: 5pm CET | 4pm UK | 11am EST | 8am PST OXON is resuming the series of masterclasses on real world evidence…
Read more

RWE & Trials Live Masterclass Session 4: ‘Individualizing Benefit Risk’

RWE Masterclass 4: ‘Individualizing Benefit Risk’ Session 4: ‘Individualizing Benefit Risk’, will take place on Wednesday, 16 June 2021 at 5 pm CEST MORE INFORMATION|REGISTER HERE   SUMMARY: Conventional methods of benefit-risk overly focus on overall results; subgroups have limitations, and the relative importance of events may not be considered. Individualizing benefit-risk more precisely would…
Read more

OXON Masterclass Series- Session3

RWE & Trials Live Masterclass Session 3: ‘Non-randomised Comparative Studies’

RWE Masterclass 3: ‘Non-randomised comparative studies’ Non-randomised comparative studies will be the main topic of the next session of our Real-World Evidence Masterclass Series. This Masterclass mini-series are meant for attendees to learn about perspectives on RWE studies with the help of two experts in this particular field: Professor Stuart Pocock, renewed trialist and statistician, and…
Read more

Masterclass 2 Propensity Scores

RWE & Trials Live Masterclass Session 2: ‘The Tyranny of Propensity Scores’

RWE Live Masterclass 2: ‘The Tyranny of Propensity Scores’ Propensity Scores will be the main topic of the next session of our Real-World Evidence Masterclass Series. This Masterclass mini-series are meant for attendees to learn about perspectives on RWE studies with the help of two experts in this particular field: Professor Stuart Pocock, renewed trialist…
Read more

RWE Masterclass

OXON’s RWE & Trials Free Live Masterclass Series 2021

Real-World Evidence & Trials Masterclass Series 2021  OXON Epidemiology will be hosting a Real-World Evidence Masterclass Series for all professionals interested in learning about the role of Real-World Data studies and their pros and cons compared with trials. Real-World Evidence (RWE) is a key opportunity to better understand the diseases and patient needs. Besides, all…
Read more

""

OXON’s WEBINARS RESUMING AFTER SUMMER SEASON

OXON will be speaking and exhibiting at World Drug Safety Congress 2019 in Amsterdam on September 10-11, 2019.

""

OXON’S LIVE WEBINAR: Germany

Understanding Health Care in Germany is our upcoming webinar. Registration is open for professionals in Pharma companies willing to learn about how to conduct observational studies in this scenario.